Abstract
A clinical study that has involved more than 150 patients up to now is being performed to test the diagnostic potential of time-resolved transmittance imaging for the detection and characterization of breast lesions. The system routinely operates at 4 wavelengths (683, 785, 913, and 975 nm), thus being sensitive to oxy-, deoxyhemoglobin, water, and lipids. Using a modified instrument operating at 7 wavelengths, images of 43 patients were acquired also at 637 and 656 nm, and proved to offer increased contrast for the detection of malignant lesions.
© 2004 Optical Society of America
PDF ArticleMore Like This
P. Taroni, A. Pifferi, L. Spinelli, A. Torricelli, G.M. Danesini, and R. Cubeddu
5138_1 European Conference on Biomedical Optics (ECBO) 2003
Lorenzo Spinelli, Alessandro Torricelli, Antonio Pifferi, Paola Taroni, Rinaldo Cubeddu, and Gian Maria Danesini
ThB5 Biomedical Topical Meeting (BIOMED) 2004
Paola Taroni, Arianna Giusto, Antonio Pifferi, Lorenzo Spinelli, Alessandro Torricelli, and Rinaldo Cubeddu
BSuB3 Biomedical Optics (BIOMED) 2008